SOX11 prevents TCF4 from binding to β-catenin by increasing its phosphorylation, leading to a decrease in the activity of the Wnt/β-catenin signaling pathway, which inhibits the growth of HCC cells and induces apoptosis. Here, TCF4 is linked to hepatocellular carcinoma.